Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rebel Medicine

Explore full profile

Biotech developing safe and effective alternatives to opioids

Salt Lake City, United StatesFounded 2020Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Rebel Medicine and the history behind them.

About Rebel Medicine

Rebel Medicine is a preclinical stage life sciences startup focused on revolutionizing pain management by developing innovative, opioid-free solutions. The company operates in the healthcare and pharmaceutical market, specifically targeting acute pain management. Rebel Medicine's primary clients include hospitals, surgical centers, and healthcare providers who are looking for effective alternatives to opioid-based pain relief.

Read full description

The company's flagship products include an injectable long-acting local anesthetic formulation for postoperative pain and a long-acting local anesthetic wound dressing for painful dermal injuries. These solutions aim to manage pain at its source, thereby eliminating the need for opioids and their associated side effects. By focusing on local pain management, Rebel Medicine addresses a critical need in the healthcare industry, where opioid addiction and its consequences are a significant concern.

Rebel Medicine's business model is built around the principles of innovation and cost-effectiveness. The company identifies important clinical needs and designs solutions from the ground up to meet those needs efficiently. By using simple materials and elegant manufacturing methods, Rebel Medicine is able to create powerful products that lower the cost of care. This approach not only makes their solutions more accessible but also ensures that they deliver value to all stakeholders, including patients, healthcare providers, and payers.

Revenue generation for Rebel Medicine comes from the sale of its pain management products to healthcare institutions. By improving the effectiveness of existing drugs and focusing on local pain management, the company provides a compelling value proposition that can lead to widespread adoption in the medical community.

In summary, Rebel Medicine is committed to creating an opioid-free future by offering innovative, cost-effective pain management solutions that benefit all stakeholders.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Salt Lake City, United States
Employees
13
Open positions
None listed
Dealroom signal
72.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Addiction, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Rebel Medicine.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jun 2025 $6M $39M Crocker Ventures · Utah Innovation Fund · Joan and Tim Fenton Founders Fund · Central Texas Angel Network
EARLY VCEquity / VC Jan 2024 $230K $39M Utah Innovation Fund
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Rebel Medicine website traffic

Latest recorded traffic for Rebel Medicine is 1.8K monthly website visits, up 20% over the last three months. Rebel Medicine's team grew 0% over the past year.

Latest monthly visits1.8K 3-month web change+20% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Kinoxis TherapeuticsA biotechnology startup developing new therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders Melbourne, Australia Operational 18 $26M $38M
Chronos TherapeuticsPre-clinical therapies for neurodegenerative and behavioral brain diseases Oxford, United Kingdom Acquired
Tay TherapeuticsBiotech platform enhancing patient-specific medicines through advanced discovery and development expertise Dundee, United Kingdom Operational
CV6 TherapeuticsCombination therapies enhancing cornerstone cancer and inflammatory treatments Belfast, United Kingdom Operational
AzellonSpin-out company from The University of Bristol focused on the development and commercialisation of a platform technology using mesenchymal stem cells infused into a biological scaffold for tissue repair - the Cell Bandage London, United Kingdom Operational
AstronauTxSmall-molecule therapeutics targeting astrocytes for neurodegenerative diseases Reading, United Kingdom Operational
ApoGlyxDeveloping new therapeutic concepts for metabolic and inflammatory diseases with innovative and proprietary Aquaporin technology Lund Municipality, Sweden Operational
CelentyxBespoke human immune cell assay services provider Birmingham, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Altitude Lab

Series A5 investors entered at this stage

  • Utah Innovation Fund
  • Crocker Ventures
  • Joan and Tim Fenton Founders Fund
  • Central Texas Angel Network
  • S.K Hart Management

Other known investors1 additional known investor

  • University of Utah
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rebel Medicine on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rebel Medicine’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.